30 Nov 2021 07:00
Director/PDMR ShareholdingAmryt Pharma plc
Director/PDMR Shareholding
The following notification is made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018).
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
1Details of the person discharging managerial responsibilities/person closely associated
a)Name
Ray Stafford
2Reason for the notification
a)Position/status
Chairman
b)Initial Notification Amendment
Initial Notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameAmryt Pharma plc
b)LEI213800YNUJEOJ8L4T95
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type ofinstrumentIdentification codeAmerican Depositary Shares
US03217L1061
b)Nature of the transaction
Purchase of Shares
c)Price(s) and volume(s)
| Price(s) | Volume(s) |
| $9.40 | 50,000 ADSs |
d)Aggregated information— Aggregated volume— Price
N/A – single transaction
e)Date of the transaction
November 29, 2021
f)Place of the transaction
NASDAQ
| ContactsJoe Wiley, CEO / Rory Nealon, CFO/COO, +353 (1) 518 0200, ir@amrytpharma.comDaniel Bush, Shore Capital, NOMAD, +44 (0) 207 408 4090, amrytcorproate@shorecap.co.ukTim McCarthy, LifeSci Advisors, LLC, +1 (212) 915 2564, tim@lifesciadvisors.comAmber Fennell, Consilium Strategic Communications, +44 (0) 203 709 5700, fennell@consilium-comms.com |